Evoke Pharma, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2007-01-01
- Employees
- 4
- Market Cap
- $3.3M
- Website
- http://www.evokepharma.com
Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis
- Conditions
- Diabetic Gastroparesis
- Interventions
- Drug: Placebo Nasal Spray
- First Posted Date
- 2014-01-01
- Last Posted Date
- 2020-07-07
- Lead Sponsor
- Evoke Pharma
- Target Recruit Count
- 205
- Registration Number
- NCT02025725
- Locations
- 🇺🇸
Birmingham Gasteroenterology Associates, P.C., Birmingham, Alabama, United States
🇺🇸Digestive Specialists of the Southeast, Dothan, Alabama, United States
🇺🇸Clinical Research Associates, Huntsville, Alabama, United States
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis
- Conditions
- Diabetic Gastroparesis
- Interventions
- Drug: Placebo Nasal Spray
- First Posted Date
- 2014-01-01
- Last Posted Date
- 2020-07-07
- Lead Sponsor
- Evoke Pharma
- Target Recruit Count
- 53
- Registration Number
- NCT02025751
- Locations
- 🇺🇸
Birmingham Gasteroenterology Associates, P.C., Birmingham, Alabama, United States
🇺🇸Digestive Specialists of the Southeast, Dothan, Alabama, United States
🇺🇸Clinical Research Associates, Huntsville, Alabama, United States
Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis
- Conditions
- GastroparesisDiabetic GastroparesisDiabetesDiabetes MellitusDelayed Gastric Emptying
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-02-18
- Last Posted Date
- 2014-06-27
- Lead Sponsor
- Evoke Pharma
- Target Recruit Count
- 287
- Registration Number
- NCT00845858
- Locations
- 🇺🇸
Digestive Specialists of the Southeast, Dothan, Alabama, United States
🇺🇸Clinical Research Associates, Huntsville, Alabama, United States
🇺🇸Medical Affiliated Research Center, Inc., Huntsville, Alabama, United States
News
Evoke Pharma Secures Patent Extension for GIMOTI Nasal Spray, Extending Market Exclusivity to 2036
Evoke Pharma received a Notice of Allowance from the USPTO for a patent application covering GIMOTI use in patients with moderate to severe gastroparesis symptoms.